Impact BioMedical Inc’s recently made public that its 10% Owner DSS, INC. unloaded Company’s shares for reported $0.85 million on Apr 04 ’25. In the deal valued at $0.95 per share,890,800 shares were sold. As a result of this transaction, DSS, INC. now holds 161,100 shares worth roughly $80550.0.
Then, Chan Heng Fai Ambrose sold 351,555 shares, generating $174,020 in total proceeds. Upon selling the shares at $0.49, the Director now owns 0 shares.
Before that, Chan Heng Fai Ambrose sold 884,776 shares. Impact BioMedical Inc shares valued at $533,636 were divested by the Director at a price of $0.60 per share. As a result of the transaction, Chan Heng Fai Ambrose now holds 351,555 shares, worth roughly $0.18 million.
Price Performance Review of IBO
On Friday, Impact BioMedical Inc [AMEX:IBO] saw its stock fall -2.92% to $0.50. Over the last five days, the stock has lost -48.57%. Impact BioMedical Inc shares have fallen nearly -65.86% since the year began.
Levels Of Support And Resistance For IBO Stock
The 24-hour chart illustrates a support level at 0.4739, which if violated will result in even more drops to 0.4528. On the upside, there is a resistance level at 0.5231. A further resistance level may holdings at 0.5512. The Relative Strength Index (RSI) on the 14-day chart is 41.46, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.6371, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.92%. Stochastics %K at 1.17% indicates the stock is a buying.
How much short interest is there in Impact BioMedical Inc?
A steep rise in short interest was recorded in Impact BioMedical Inc stocks on 2025-03-31, growing by 0.11 million shares to a total of 0.12 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 9293.0 shares. There was a rise of 92.27%, which implies that there is a positive sentiment for the stock.
